Patent · US Active

Heterodimeric antibodies that bind CD3 and CD38

US12129309B2 · kind B2 · utility

0Cited by

136References

13Claims

0Family size

Assignee

Xencor, Inc. · US

Inventors

Matthew Bernett · Monrovia, US
Gregory Moore · Monrovia, US
John Desjarlais · Pasadena, US
Seung Chu · Cypress, US
Rumana Rashid · Temple City, US
Umesh Muchhal · Monrovia, US

Key dates

Filing date	May 4, 2022
Grant date	Oct 29, 2024
Priority date	—
Expiry date	Aug 5, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.